GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Friday. Here’s a look at the key stocks to watch in trade.
Stocks in Focus: GIFT Nifty was trading 52 points or 0.22% higher at 23,915 indicating a higher start for domestic indices NSE Nifty 50 and BSE Sensex on Friday. Previously, on Thursday, the NSE Nifty 50 closed the session 22.5 points or 0.10% higher at 23,750, while the BSE Sensex closed flat at 78,472.
Stocks to watch on December 27, 2024
IndusInd Bank
IndusInd Bank plans to sell nearly Rs 1,500 crore worth of bad loans, including more than 1 million microloans with a ticket size anywhere between Rs 5,000 and Rs 40,000, to asset reconstruction companies (ARCs), in a bid to arrest deterioration in its asset quality. The bank has nearly 1.06 million microloan accounts of farmers spread across the country and is looking to transfer them under the all-cash deal, told a source to Financial Express.
Religare Enterprises
In a setback to the Burman family, the Madhya Pradesh High Court has stayed the approval granted by the Reserve Bank of India (RBI) for making an open offer to acquire an additional 26% stake in Religare Enterprises as well as the company’s annual general meeting (AGM) scheduled for December 31.
Reliance Power
The Delhi High Court has granted interim relief to Reliance Power’s subsidiary, Reliance NU BESS, in a petition pertaining to disqualification from participating in three bids solely on the ground of the debarment order dated November 6, issued by Solar Energy Corporation of India (SECI), against the petitioner.
Acme Solar Holdings
ACME Renewtech, a subsidiary of Acme Solar Holdings, announced that it has successfully secured Rs 1,988 crore in term loan financing from Power Finance Corporation (PFC) to fund the development and construction of a 300 MW Solar-Wind Hybrid Renewable Energy Project.
Mankind Pharma
Mankind Pharma and Innovent Biologics announced a partnership to exclusively license and commercialise the innovative immunotherapy drug Sintilimab, used in the treatment of cancer, in the Indian market.
RBL Bank
RBL Bank has sold its entire 8.16% stake in DAM Capital Advisors Limited through an offer for sale (OFS) after the latter’s initial public offering (IPO),
» Read More
